Early IL-10 producing B-cells and coinciding Th/Tr17 shifts during three year grass-pollen AIT

EBioMedicine. 2018 Oct:36:475-488. doi: 10.1016/j.ebiom.2018.09.016. Epub 2018 Oct 11.

Abstract

Unlabelled Image

Background: Allergen-specific immunotherapy (AIT) is a causative treatment in allergic airway disease, comprising long-term allergen administration and requiring three years of treatment. Mechanisms and biomarkers that translate into clinical efficacy remain urgently needed.

Methods: In an exploratory observational allergy cohort we phenotyped 32 grass-pollen allergic patients with hayfever undergoing AIT for over three years and controls using local and systemic samples for ex vivo FACS, nasal transcriptomes and in vitro phleum-stimulation at critical time windows six hours after therapeutic allergen administration and during peak-season responses.

Findings: The up-dosing phase is marked by increased IL-10+ B-cells with allergen-specific PD-L1 up-regulation, while effector Th1/Th17 cells and CCR6+IL-17+FoxP3+T-cells decrease. The conversion phase exhibits Th17 recovery in the absence of Th2 cells. The tolerance-mounting phase after three years of treatment is characterized by induction of Tregs while Th2 and phleum-specific Th17 responses decrease. Notably, high ratios of circulating Breg/Th17 following initial AIT correlate significantly with clinical improvement after three years.

Interpretation: Our exploratory data hypothezise differential shifts in the hierarchy of tolerance in three distinct phases of AIT characterized by conversion of regulatory against pro-inflammatory mechanisms, of which the Breg/Th17 ratio after initial treatment emerges as potential early prediction of AIT efficacy.

Fund: This study was partially funded by Allergopharma GmbH & Co. KG, intramural funding and the German Center for Lung Research (DZL).

Keywords: Allergic Rhinitis; Allergy; Biomarker; Prediction; Regulatory B-cells (Bregs); Regulatory T-cells (Tregs); Specific Immunotherapy; Surrogate; Tolerance.

MeSH terms

  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism*
  • Cells, Cultured
  • Desensitization, Immunologic*
  • Humans
  • Interleukin-10 / metabolism*
  • Poaceae / immunology
  • Pollen / immunology*
  • Rhinitis, Allergic, Seasonal / therapy*
  • T-Lymphocytes / immunology*

Substances

  • Interleukin-10